CymitQuimica logo

CAS 1130067-06-9

:

Fórmula:C26H28Cl2N4O2
InChI:InChI=1S/C26H27ClN4O2.ClH/c1-17(28-25(32)20-7-6-18-4-2-3-5-19(18)14-20)16-30-12-10-22(11-13-30)31-24-9-8-21(27)15-23(24)29-26(31)33;/h2-9,14-15,17,22H,10-13,16H2,1H3,(H,28,32)(H,29,33);1H/t17-;/m0./s1
Chave InChI:RQULTQQAHGYYDG-LMOVPXPDSA-N
SMILES:C[C@@H](CN1CCC(CC1)N2C3=C(C=C(C=C3)Cl)NC2=O)NC(=O)C4=CC5=CC=CC=C5C=C4.Cl
Foram encontrados 6 produtos.
  • VU0155069

    CAS:
    VU0155069
    Fórmula:C26H27ClN4O2
    Pureza:99.5%
    Peso molecular:462.97

    Ref: 54-BUP05641

    2mg
    57,00€
    5mg
    89,00€
    10mg
    150,00€
    25mg
    274,00€
    50mg
    475,00€
    100mg
    794,00€
  • VU-0155069

    CAS:
    VU-0155069
    Fórmula:C26H27ClN4O2
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:462.97117

    Ref: 54-BISN0085

    1mg
    42,00€
  • VU0155069

    CAS:
    Fórmula:C26H28Cl2N4O2
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:499.4321

    Ref: IN-DA0081MP

    1mg
    61,00€
    5mg
    173,00€
    10mg
    266,00€
    25mg
    618,00€
    50mg
    741,00€
  • VU-0155069

    CAS:
    VU-0155069 is a small molecule that inhibits fatty acid uptake and metabolism in the kidney. It has been shown to suppress tumor growth in a mouse model of breast cancer by inhibiting fatty acid uptake and metabolism, which reduces the production of proinflammatory molecules. VU-0155069 also inhibits the cation channel CLCN2 in glioma patients, which leads to reduced tumor growth. This drug has shown efficacy in human clinical trials for patients with chronic kidney disease who have not responded to other therapies. VU-0155069 is being investigated as an adjuvant treatment for glioma patients who have already undergone surgery or radiation therapy. VU-0155069 can be used to treat neurodegenerative diseases such as Parkinson's disease by restoring synaptic dysfunction and reducing inflammation.
    Fórmula:C26H27ClN4O2
    Pureza:Min. 95%
    Peso molecular:462.97 g/mol

    Ref: 3D-FVB06706

    25mg
    1.058,00€
    50mg
    1.388,00€
    100mg
    2.163,00€
  • VU0155069

    CAS:
    VU0155069, a selective PLD1 inhibitor (IC50: 46 nM), halts cancer cell migration in transwell assays.
    Fórmula:C26H27ClN4O2
    Pureza:99.5%
    Cor e Forma:White Solid
    Peso molecular:462.97